ZA835326B - Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same - Google Patents

Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Info

Publication number
ZA835326B
ZA835326B ZA835326A ZA835326A ZA835326B ZA 835326 B ZA835326 B ZA 835326B ZA 835326 A ZA835326 A ZA 835326A ZA 835326 A ZA835326 A ZA 835326A ZA 835326 B ZA835326 B ZA 835326B
Authority
ZA
South Africa
Prior art keywords
caffeine
analgesic
methods
same
inflammatory compositions
Prior art date
Application number
ZA835326A
Inventor
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of ZA835326B publication Critical patent/ZA835326B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA835326A 1982-07-22 1983-07-21 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same ZA835326B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22

Publications (1)

Publication Number Publication Date
ZA835326B true ZA835326B (en) 1984-09-26

Family

ID=23584242

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA835324A ZA835324B (en) 1982-07-22 1983-07-21 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
ZA835326A ZA835326B (en) 1982-07-22 1983-07-21 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA835324A ZA835324B (en) 1982-07-22 1983-07-21 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Country Status (15)

Country Link
JP (3) JPS59501459A (en)
AT (2) AT389226B (en)
AU (1) AU558485B2 (en)
BE (1) BE897356A (en)
CA (1) CA1217429A (en)
CH (1) CH659391A5 (en)
DE (1) DE3390116C2 (en)
FR (1) FR2530469A1 (en)
GB (1) GB2134786B (en)
IE (1) IE55367B1 (en)
IT (1) IT1206502B (en)
NL (1) NL191432C (en)
SE (1) SE466481B (en)
WO (1) WO1984000488A1 (en)
ZA (2) ZA835324B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
CH669523A5 (en) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
EP1414458B1 (en) 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (en) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd Fatigue recovery agent
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP7523879B2 (en) * 2016-10-31 2024-07-29 エスエス製薬株式会社 Pharmaceutical Compositions
JP2021054728A (en) * 2019-09-27 2021-04-08 興和株式会社 Pharmaceutical
JP6811453B1 (en) * 2020-06-24 2021-01-13 医療法人すぎやま内科 Composition for transdermal absorption

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
GB8406704D0 (en) 1984-04-18
IT8322173A0 (en) 1983-07-21
NL191432B (en) 1995-03-01
DE3390116T1 (en) 1985-01-10
AU558485B2 (en) 1987-01-29
GB2134786A (en) 1984-08-22
JPS59501460A (en) 1984-08-16
BE897356A (en) 1983-11-14
AU1881683A (en) 1984-02-23
AT389226B (en) 1989-11-10
DE3390116C2 (en) 1994-06-16
ATA245988A (en) 1989-08-15
FR2530469A1 (en) 1984-01-27
ATA903983A (en) 1989-04-15
NL191432C (en) 1995-07-04
SE8401538D0 (en) 1984-03-20
SE8401538L (en) 1984-03-20
SE466481B (en) 1992-02-24
AT389998B (en) 1990-02-26
GB2134786B (en) 1986-05-08
CH659391A5 (en) 1987-01-30
WO1984000488A1 (en) 1984-02-16
NL8320240A (en) 1984-06-01
IT1206502B (en) 1989-04-27
JPS59501459A (en) 1984-08-16
JPH07165583A (en) 1995-06-27
CA1217429A (en) 1987-02-03
ZA835324B (en) 1984-09-26
IE55367B1 (en) 1990-08-29
IE831715L (en) 1984-01-22

Similar Documents

Publication Publication Date Title
GB2161076B (en) Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
ZA849680B (en) Analgesic and anti-inflammatory compositions comprising xanthine and methods of using same
GB2162747B (en) Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
ZW20383A1 (en) Compounds compositions and methods of use therefor
DE3372705D1 (en) Pharmaceutical composition and its use
GB2134786B (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB2132891B (en) Improved analgesic and anti-inflammatory compositions comprising ibuprofen and method of using same
GB2182323B (en) Settable compositions and methods of use thereof
AU8258282A (en) Analgesic compositions and methods of use
PH17898A (en) Analgesic mixture of nalsuphine and isuprofen
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
GB2113338B (en) Grouting composition and method of using same
GB2160893B (en) Soldering compositions and methods of use
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
GB8319146D0 (en) Formulations of vinca alkaloids
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
GB2123417B (en) Preparation and use of metal dithiobenzoates
DE3261724D1 (en) Analgesic and anti-inflammatory composition
PH17913A (en) Analgesic mixture of nalbuphine and flurbiprofen
DE3276871D1 (en) Preparation of 6-deoxy-d-fructose and 6-deoxy-l-sorbose
PH21826A (en) N-aryl-n(-piperidinyl)-alkoxyalkylamides and pharmaceutical compositions and methods of use employing such compounds
ZA835081B (en) Formulations of vinca alkaloids
PH17118A (en) Antihypertensive pharmaceutical compositions and its method of use
PT76389B (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect
PH16339A (en) Dermatological compositions and method of use thereof